Tag: kidney cancer

March 26, 2018 Off

BMS gets CHMP’s nod for Opdivo as four-week dosing for skin cancer and treated kidney cancer

Bristol-Myers Squibb said on Monday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…

November 24, 2015 Off

Bristol-Myres Squid’s Opdivo gets FDA’s nod (kidney cancer)

By Dino Mustafić

The U.S. Food and Drug Administration has approved Bristol-Myers Squibb-marketed Opdivo (nivolumab) to treat patients with advanced form of kidney cancer.